ENDRA Life Sciences (Nasdaq: NDRA)’s Post

View profile for François Michelon, graphic

CEO & Board Chair @ ENDRA Life Sciences (Nasdaq: NDRA) • MedTech Innovation • IPO • Transforming Early Detection of Liver Disease

Had a great discussion on The Wall Street Resource about Steatotic Liver Disease, approaching game-changing therapies, and the need for better diagnostics. Listen here: https://lnkd.in/eFMJYeu #ENDRA #SLD #TAEUS #MASLD

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics